Delhi: Vaccine screening for 6-12 years old starts at AIIMS

The All India Institute of Medical Sciences (AIIMS) is learnt to have started screening of children aged 6-12 years for the clinical trials of India's first indigenously developed Covid-19 vaccine, Bharat Biotech's Covaxin.

Delhi AIIMS has decided to start the trial drive after the recruitment and clinical trial for single-dose Covaxin for 12-18 age group is over.

After the recruitment of 6-12 year-old children, AIIMS Delhi will be conducting trials for the age group 2-6 years of children. The trials are taking place at 525 centres.